Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Rajesh Shrotriya | M | 79 | 17 Jahre | |
| Samuel Gulko | M | 92 | 6 Jahre | |
| Thomas Miller | M | 69 |
CoCensys, Inc.
 CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 Jahre |
| Luigi Lenaz | M | 83 | 8 Jahre | |
| Lowell E. Sears | M | 73 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 4 Jahre |
| David A. H. Lee | M | 74 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 5 Jahre |
| John McManus | M | 60 | 1 Jahre | |
| Edward P. Monaghan | M | - |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | - |
| Michael P. McManus | M | 54 | 2 Jahre | |
| Bob Holmen | M | 60 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 2 Jahre |
| Douglas Scott Wieland | M | 64 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 7 Jahre |
| Ernest H. Pfadenhauer | M | - | 6 Jahre | |
| James H. Coleman | M | 82 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | - |
| Kimberly E. Vanover | M | 58 |
CoCensys, Inc.
CoCensys, Inc. Pharmaceuticals: MajorHealth Technology CoCensys, Inc. discovers and develops drugs to treat neurological and psychiatric disorders. The company's product development programs focus on two novel and proprietary classes of compounds: Epalons, to treat epilepsy, migraine, anxiety and sleep disorders and Excitatory Amino Acid (EAA) receptor antagonists, to treat stroke, head trauma, epilepsy and Parkinson's disease. The company was founded in 1989 and is located in Irvine, CA. | 5 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 14 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- David Brian Fick
- Persönliches Netzwerk
